The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery
Open accessAbstract
BACKGROUND: Levosimendan is an inotropic agent that has been shown in small studies to prevent or treat the low cardiac output syndrome after cardiac surgery. METHODS: In a multicenter, randomized, placebo-controlled, phase 3 trial, we evaluated the efficacy and safety of levosimendan in patients with a left ventricular ejection fraction of 35% or less who were undergoing cardiac surgery with the use of cardiopulmonary bypass. Patients were randomly assigned to receive either intravenous levosimendan (at a dose of 0.2 μg per kilogram of body weight per minute for 1 hour, followed by a dose of 0.1 μg per kilogram per minute for 23 hours) or placebo, with the infusion started before surgery. The two primary end points were a four-component composite of death through day 30, renal-replacement therapy through day 30, perioperative myocardial infarction through day 5, or use of a mechanical cardiac assist device through day 5; and a two-component composite of death through day 30 or use of a mechanical cardiac assist device through day 5. RESULTS: A total of 882 patients underwent randomization, 849 of whom received levosimendan or placebo and were included in the modified intention-to-treat population. The four-component primary end point occurred in 105 of 428 patients (24.5%) assigned to receive levosimendan and in 103 of 421 (24.5%) assigned to receive placebo (adjusted odds ratio, 1.00; 99% confidence interval [CI], 0.66 to 1.54; P=0.98). The two-component primary end point occurred in 56 patients (13.1%) assigned to receive levosimendan and in 48 (11.4%) assigned to receive placebo (adjusted odds ratio, 1.18; 96% CI, 0.76 to 1.82; P=0.45). The rate of adverse events did not differ significantly between the two groups. CONCLUSIONS: Prophylactic levosimendan did not result in a rate of the short-term composite end point of death, renal-replacement therapy, perioperative myocardial infarction, or use of a mechanical cardiac assist device that was lower than the rate with placebo among patients with a reduced left ventricular ejection fraction who were undergoing cardiac surgery with the use of cardiopulmonary bypass. (Funded by Tenax Therapeutics; LEVO-CTS ClinicalTrials.gov number, NCT02025621 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
2014 AHA/ACC guideline for the management of patients with valvular heart disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.05.014 · Cited by 989
Writing Committee Members, Hillis, L. D., Smith, P. K., Anderson, J. L., Bittl, J. A., Bridges, C. R., Byrne, J. G., Cigarroa, J. E., DiSesa, V. J., Hiratzka, L. F., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31823c074e · Cited by 781
Thackray, S., Easthaugh, J., Freemantle, N., & Cleland, J. G. F. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(02)00041-7 · Cited by 321
Lilleberg, J. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0806 · Cited by 261
Algarni, K. D., Maganti, M., & Yau, T. M. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2011.06.017 · Cited by 152
Bridgewater, B., Grayson, A. D., Brooks, N. H., Grotte, G. J., Fabri, B. M., Au, J., Hooper, T., Jones, M. T., & Keogh, B. E. (2007) · Heart · doi:10.1136/hrt.2006.106393 · Cited by 148
Effect of Levosimendan on Survival and Adverse Events After Cardiac Surgery: A Meta-Analysis
Harrison, R. W., Hasselblad, V., Mehta, R. H., Levín, R., Harrington, R. A., & Alexander, J. H. (2013) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2013.03.027 · Cited by 124
Self-citationLevín, R., Degrange, M. A., del Mazo, C. D., Tanús, E., & Porcile, R. (2012) · Europe PMC (PubMed Central) · Cited by 118
Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion
Toller, W. G., Heringlake, M., Guarracino, F., Algotsson, L., Álvarez, J., Argyriadou, H., Gal, T. B., Černý, V., Cholley, B., Eremenko, A., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.02.022 · Cited by 106
Self-citation
Cited by
Management of cardiogenic shock complicating myocardial infarction: an update 2019
Thiele, H., Ohman, E. M., de Waha-Thiele, S., Zeymer, U., & Desch, S. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz363 · Cited by 683
2019 EACTS Expert Consensus on long-term mechanical circulatory support
Potapov, E. V., Antonides, C., Crespo-Leiro, M. G., Combes, A., Färber, G., Hannan, M. M., Kukucka, M., de Jonge, N., Loforte, A., Lund, L. H., et al. (2019) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezz098 · Cited by 399
Joannidis, M., Druml, W., Forni, L. G., Groeneveld, A. B. J., Honore, P. M., Hoste, E., Ostermann, M., Oudemans-van Straaten, H. M., & Schetz, M. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4832-y · Cited by 340
Nadim, M. K., Forni, L. G., Bihorac, A., Hobson, C., Koyner, J. L., Shaw, A., Arnaoutakis, G. J., Ding, X., Engelman, D. T., Gasparovic, H., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008834 · Cited by 340
Self-citationLevosimendan for Hemodynamic Support after Cardiac Surgery
Landoni, G., Lomivorotov, V. V., Alvaro, G., Lobreglio, R., Pisano, A., Guarracino, F., Calabrò, M. G., Grigoryev, E. V., Likhvantsev, V. V., Salgado-Filho, M. F., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616325 · Cited by 300
Metadata
- Authors
- Mehta, R. H., Leimberger, J. D., van Diepen, S., Meza, J., Wang, A., Jankowich, R., Harrison, R. W., Hay, D., Fremes, S., Duncan, A., Soltesz, E. G., Luber, J., Park, S., Argenziano, M., Murphy, E., Marcel, R., Kalavrouziotis, D., Nagpal, D., Bozinovski, J., Toller, W., Heringlake, M., Goodman, S. G., Levy, J. H., Harrington, R. A., Anstrom, K. J., & Alexander, J. H.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-05-25
- Volume
- 376
- Issue
- 21
- Pages
- 2032-2042
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2596970432
- Cited by
- 311
- References
- 14
- FWCI
- 39.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery. https://app.cochat.ai/papers/10.1056/nejmoa1616218
- The paper
- Mehta, R. H., Leimberger, J. D., van Diepen, S., Meza, J., Wang, A., Jankowich, R., Harrison, R. W., Hay, D., Fremes, S., Duncan, A., Soltesz, E. G., Luber, J., Park, S., Argenziano, M., Murphy, E., Marcel, R., Kalavrouziotis, D., Nagpal, D., Bozinovski, J., . . . Alexander, J. H. (2017). Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1616218
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.